Elai Davicioni

18.2k total citations · 1 hit paper
296 papers, 7.1k citations indexed

About

Elai Davicioni is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Elai Davicioni has authored 296 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 227 papers in Pulmonary and Respiratory Medicine, 120 papers in Cancer Research and 79 papers in Molecular Biology. Recurrent topics in Elai Davicioni's work include Prostate Cancer Treatment and Research (200 papers), Prostate Cancer Diagnosis and Treatment (116 papers) and Cancer, Lipids, and Metabolism (67 papers). Elai Davicioni is often cited by papers focused on Prostate Cancer Treatment and Research (200 papers), Prostate Cancer Diagnosis and Treatment (116 papers) and Cancer, Lipids, and Metabolism (67 papers). Elai Davicioni collaborates with scholars based in United States, Canada and United Kingdom. Elai Davicioni's co-authors include Timothy J. Triche, Nicholas Erho, R. Jeffrey Karnes, Robert B. Den, Felix Y. Feng, Christine Buerki, Edward M. Schaeffer, Mohammed Alshalalfa, Kasra Yousefi and Robert B. Jenkins and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Elai Davicioni

271 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

2013 427 citations Nicholas Erho, Anamaria Crisan et al. profile →

Peers

Countries citing papers authored by Elai Davicioni

Since Specialization

Citations

This map shows the geographic impact of Elai Davicioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elai Davicioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elai Davicioni more than expected).

Fields of papers citing papers by Elai Davicioni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elai Davicioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elai Davicioni. The network helps show where Elai Davicioni may publish in the future.

Co-authorship network of co-authors of Elai Davicioni

This figure shows the co-authorship network connecting the top 25 collaborators of Elai Davicioni. A scholar is included among the top collaborators of Elai Davicioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elai Davicioni. Elai Davicioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy 2025 ·European Urology Open Science ·Joep J. de Jong, (unknown), Siamak Daneshmand, Robert S. Svatek, Vikram M. Narayan, Elai Davicioni, Shreyas Joshi, (unknown), Roger Li, Brant A. Inman, Paras Shah, (unknown), Jonathan L. Wright, Ewan A. Gibb, Yair Lotan	1
2	Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy 2025 ·Theranostics ·(unknown), (unknown), (unknown), Christopher Darr, Elai Davicioni, Kuangyu Shi, (unknown), (unknown), (unknown), Katharina Lückerath, Boris Hadaschik, Robert Seifert	0
3	From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer 2024 ·Cancers ·(unknown), (unknown), Hisham F. Bahmad, (unknown), Ryan W. Dobbs, (unknown), Wassim Abou‐Kheir, Elai Davicioni, David I. Lee, Mohammed Shahait	11
4	Quantification and molecular correlates of tertiary lymphoid structures in primary prostate cancer 2024 ·The Prostate ·Mohammed Shahait, (unknown), (unknown), (unknown), Elai Davicioni, (unknown), (unknown), David I. Lee, Priti Lal	3
5	Upper tract urothelial cancer (UTUC) genomic profiling and correlation regarding benefit of platinum-based chemotherapy 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Joep J. de Jong, Elai Davicioni, Wenping Li, Jeanny B. Aragon‐Ching	0
6	Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), Claudia Kesch, Wolfgang P. Fendler, (unknown), Yang Liu, (unknown), Elai Davicioni, Jason D. Hughes, Hong Song, Katharina Lueckerath, Ken Herrmann, Boris Hadaschik, Robert Seifert	4
7	Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology 2023 ·Seminars in Radiation Oncology ·Philip Sutera, Heath D. Skinner, Matthew E. Witek, Mark V. Mishra, Young Kwok, Elai Davicioni, Felix Y. Feng, Daniel Y. Song, E.M. Nichols, Phuoc T. Tran, Carmen Bergom	2
8	Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI 2023 ·Cancers ·Radka Stoyanova, Olmo Zavala‐Romero, Deukwoo Kwon, (unknown), (unknown), Ahmad Algohary, (unknown), Sandra M. Gaston, Patricia Castillo, Oleksandr N. Kryvenko, Elai Davicioni, Bruno Nahar, Benjamin Spieler, Matthew C. Abramowitz, Alan Dal Pra, Dipen J. Parekh, Sanoj Punnen, Alan Pollack	3
9	Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM Trial 2023 ·JCO Precision Oncology ·Rhonda L. Bitting, Yuan Wu, Jason A. Somarelli, (unknown), Yang Liu, Elai Davicioni, Daniel J. George, Andrew J. Armstrong	6
10	Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer 2021 ·Journal of Clinical Investigation ·Deli Liu, Michael A. Augello, Ivana Grbeša, Davide Prandi, Yang Liu, Jonathan E. Shoag, R. Jeffrey Karnes, Bruce J. Trock, Eric A. Klein, Robert B. Den, Francesca Demichelis, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri	27
11	Clinical-genomic Characterization Unveils More Aggressive Disease Features in Elderly Prostate Cancer Patients with Low-grade Disease 2020 ·European Urology Focus ·Hanan Goldberg, Daniel E. Spratt, Thenappan Chandrasekar, Zachary Klaassen, Christopher J.D. Wallis, María Santiago‐Jiménez, Nick Fishbane, Elai Davicioni, (unknown), Ardalan E. Ahmad, Jaime O. Herrera‐Cáceres, Shabbir M.H. Alibhai, Alejandro Berlín, Neil Fleshner	6
12	Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy 2019 ·Clinical Cancer Research ·Martin Sjöström, S. Laura Chang, Nick Fishbane, Elai Davicioni, Linda Hartman, Erik Holmberg, Felix Y. Feng, Corey Speers, Lori J. Pierce, Per Malmström, Mårten Fernö, Per Karlsson	12
13	Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression 2019 ·Cancer Research ·Robert M. Hughes, Brian W. Simons, (unknown), Rebecca L. Miller, (unknown), (unknown), Debebe Theodros, Michael C. Haffner, Tamara L. Lotan, Jessie Huang, Elai Davicioni, Steven S. An, Ryan C. Riddle, Daniel L.J. Thorek, Isla P. Garraway, Elana J. Fertig, John T. Isaacs, W. Nathaniel Brennen, Ben Ho Park, Paula J. Hurley	52
14	Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types 2019 ·Clinical Cancer Research ·William S. Chen, Mohammed Alshalalfa, Shuang G. Zhao, Yang Liu, Brandon A. Mahal, David A. Quigley, Ting Wei, Elai Davicioni, Timothy R. Rebbeck, Philip W. Kantoff, Christopher A. Maher, Karen E. Knudsen, Eric J. Small, Paul L. Nguyen, Felix Y. Feng	34
15	Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome 2016 ·Cancer Research ·Sungyong You, Beatrice S. Knudsen, Nicholas Erho, Mohammed Alshalalfa, Mandeep Takhar, Hussam Al-Deen Ashab, Elai Davicioni, R. Jeffrey Karnes, Eric A. Klein, Robert B. Den, Ashley E. Ross, Edward M. Schaeffer, Isla P. Garraway, Jayoung Kim, Michael R. Freeman	132
16	The Frequency of Druggable Targets in Localized Prostate Cancer: Initial Analysis From a Commercially Available Genomic Expression Database in Urologic Cancer 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Robert B. Den, Elai Davicioni, Mandeep Takhar, Nicholas Erho, Lucia L.C. Lam, H.A.D.M. Ashab, (unknown), Magnus T. Dillon, Kasra Yousefi, (unknown), (unknown)	1
17	Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression 2015 ·Cancer Research ·Paula J. Hurley, Robert M. Hughes, Brian W. Simons, Jessie Huang, Rebecca M. Miller, Brian Shinder, Michael C. Haffner, David Esopi, Yasunori Kimura, (unknown), Ashley E. Ross, Nicholas Erho, Ismael A. Vergara, Sheila F. Faraj, Elai Davicioni, George J. Netto, Srinivasan Yegnasubramanian, Steven S. An, Edward M. Schaeffer	22
18	The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer 2015 ·Clinical Cancer Research ·Shuang G. Zhao, Joseph R. Evans, Vishal Kothari, Grace Y. Sun, (unknown), (unknown), Edward M. Schaeffer, Ashley E. Ross, Eric A. Klein, Robert B. Den, Adam P. Dicker, R. Jeffrey Karnes, Nicholas Erho, Paul L. Nguyen, Elai Davicioni, Felix Y. Feng	43
19	Whole-Transcriptome Profiling of Thyroid Nodules Identifies Expression-Based Signatures for Accurate Thyroid Cancer Diagnosis 2013 ·The Journal of Clinical Endocrinology & Metabolism ·Sam M. Wiseman, Zaid Haddad, Blair Walker, Ismael A. Vergara, Thomas Sierocinski, Anamaria Crisan, Mercedeh Ghadessi, Phuong Dao, Benedikt Zimmermann, Timothy J. Triche, Nicholas Erho, Elai Davicioni	15
20	Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas 2006 ·Cancer Research ·Elai Davicioni, Friedrich Graf Finckenstein, Violette Shahbazian, Jonathan D. Buckley, Timothy J. Triche, Michael J. Anderson	234

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact